baber/WOPTO huggingface dataset:
Patent NZ-519620-A (NZ)
Title: Telephone adapter
Inventor: DREWNICKI RICHARD
IPC: H01R31/06
Filed: 2000-12-15
Abstract: A telephone adapter (10) for use with a telephone plug (21) having at least one male member (25) and a telephone socket (not shown), the plug and socket, so that a telephone plug (21) can be mounted in a telephone socket (not shown) with the adapter (10) therebetween, the at least one male member (25) of the telephone plug (21) passing through the at least one hole (3) of the adapter into the telephone socket to support the telephone adapter and to connect the telephone plug (27) or socket (5) of the second standard to the socket of the first standard via the interconnections, the contacts and the male member of the plug.
Patent NZ-523126-A (NZ)
Title: Sprayable wound care compositions comprising gellan gum
Inventor: COURT ANDREW
IPC: A61P17/02
Filed: 2001-06-28
Abstract: A composition for the treatment of wound or skin injury that is in a sprayable form prior to application to the wound. The composition is composed of from 0.25% to 1.5% by weight of the composition of a gellan gum the viscosity of which increases once applied to a wound so that an immobile gel is formed.
Patent NZ-523684-A (NZ)
Title: New pharmaceutical composition
Inventor: BARBIER PIERRE
IPC: A61K31/56
Filed: 2001-07-19
Abstract: A pharmaceutical composition comprising orlistat and a bile acid sequestrant selected from cholestyramine, colestipol, coleselevam, colestimide, sevelamer, cellulose derivates, dextran derivatives, starch and starch derivatives is described. The composition is useful for the treatment or prevention of obesity. The bile acid sequestrant can be used in the manufacture of medicament for the treatment or prevention of gastrointestinal side effects selected from oily spotting, fatty/oily stools, fecal urgency, increased defecation and fecal incontinence.
Patent NZ-535314-A (NZ)
Title: Combination treatments for chemokine-mediated diseases
Inventor: TAVERAS ARTHUR G
IPC: A61P1/02
Filed: 2003-03-17
Abstract: A use of one or more compounds of formula (I) or a pharmaceutical acceptable salt or solvate thereof, in combination with other classes of pharmaceutical compounds; for the manufacture of one or more medicaments for treating a CXC chemokine mediated disease is disclosed, wherein the variables shown in formula (I) are as defined in the specification. These compounds of formula (I) in combination with other classes of pharmaceutical compounds are particularly suitable for treating chemokine-mediated diseases such as acute and chronic inflammatory disorders, psoriasis, cystic fibrosis, asthma, cancer and many other diseases as disclosed in the specification.
Patent NZ-536658-A (NZ)
Title: Method for assembling gas turbine engine components
Inventor: SIDWELL CARROLL V
IPC: F02C7/00
Filed: 2004-11-18
Abstract: Method for assembling into turbine sets turbine components having internal cooling passages. The turbine components are classified according to flow capability through the internal cooling passages and turbine sets are assembled in which the turbine components have the same flow capability classification.
Patent NZ-539029-A (NZ)
Title: On-machine-seamable industrial fabric comprised of interconnected rings
Inventor: HANSEN ROBERT A
IPC: D21F1/00
Filed: 2003-10-28
Abstract: Disclosed is an on- machine-seamable industrial fabric comprising rings connected by pintles. In one principal embodiment, the rings are oriented in the machine direction and the pintles extend at an angle, connecting the rings. Such configuration improves the strength of the fabric and provides resistance to needling damage. In another principal embodiment, the rings are oriented in the cross-machine direction and the pintles extend in the machine direction, joining the rings.
Patent NZ-539925-A (NZ)
Title: Biologically inhibiting material a method of producing said material as well as the use of said material for inhibiting live cells
Inventor: MOLLER PER
IPC: A61L9/16
Filed: 2003-11-19
Abstract: Biologically inhibiting material contains an anode material and a cathode material and The material inhibits live cells coming into contact with or close to the material. The anode and cathode materials have a positive galvanic material and the potential of the cathode material is higher than the potential of the anode material. The biologically inhibiting material includes a surface with separated areas of anode material and cathode material. The distance between any point on the active surface and both the adjacent cathode material and the adjacent anode material does not exceed 200 micrometers. The cathode material is Au, Pd, Pt, Ru, Ir or Rh and the anode material is Au of Ag.
Patent NZ-540479-A (NZ)
Title: Beer dispensing system with gas pressure reservoir
Inventor: WAUTERS ALBERT
IPC: B67D1/04
Filed: 2003-11-25
Abstract: A home beer dispensing apparatus has a keg having a self-contained bag filled with a beer and a pressure system. The pressure system creates a pressurized air space between the keg inner walls and the bag to assist in the dispensing of the beer. The pressure system has a keg one-way air valve mounted to a top wall of the keg to permit entry of pressurized air into the keg. The pressure system has a pressure reservoir mounted in the dispensing apparatus outside the keg and in fluid flow communication with the keg one-way valve. The reservoir stores a charge of pressurized air and supplies at least a portion of this charge to the keg through the keg air valve when the dispensing apparatus is operated to dispense the beer. The reservoir provides a reserved charge of pressurized gas that is on hand to reduce dampening pressure fluctuations during beer dispensing which can result in beer frothing, especially during the early stages of beer dispensing when the air head space in the keg is small. Further, the apparatus may also have a pressure sensing system adapted to measure time rate of pressure change in the keg. The apparatus has a signalling device responsive to the time rate of pressure change in the keg to produce a signal related to volume of beer remaining in the bag. Preferably, the signal is displayed visually on the dispensing apparatus. This application is directed towards the beverage dispensing aspect.
Patent NZ-543917-A (NZ)
Title: Fragrance delivery system
Inventor: ATENCIA TONI BRONCANO
Filed: 2005-12-02
Abstract: A delivery system for periodically releasing fragrances selected from a group of at least two different fragrances is disclosed. The system includes a control unit (2) with a selection unit for selecting a fragrance from at least two fragrances and controlling a release mechanism (3) to release the selected fragrance. A switching element for switches the release mechanism between a first state and a second state or vice versa, where in the first state the fragrance is released at a higher rate than in the second state. The switching element is arranged to switch the release mechanism between the first and second states during first and second alternating periods of time. In the second period of time the ratio of the duration of the first state relative to the duration of the second state is lower than in the first period of time. To help prevent fragrance habituation, the second period is sufficiently long to reduce the detection level of a human being, such as to the level before habituation.
Patent NZ-543973-A (NZ)
Title: Gasoline composition
Inventor: CRACKNELL ROGER FRANCIS
IPC: C10L1/18
Filed: 2004-06-17
Abstract: Disclosed is a gasoline composition comprising a hydrocarbon base fuel containing 5 to 20% v olefins, not greater than 5% v olefins of at least 20 carbon atoms, not greater than 5% v aromatics of at least 10 carbon atoms, initial boiling point in the range 24 to 45 degrees Celsius, T10 in the range 38 to 60 degrees Celsius, T50 in the range 77 to 110 degrees Celsius, T90 in the range 130 to 190 degrees Celsius and final boiling point not greater than 220 degrees Celsius.
Patent NZ-552066-A (NZ)
Title: Optical inspection of surfaces open to different directions in a piece of material
Inventor: PAAVOLA JYRI
IPC: G01B/
Filed: 2005-04-12
Abstract: A device for optical inspection of open surfaces (19) of objects from at least two different viewing directions (P1, P2) comprises illuminating means for illuminating the open surfaces of the objects; and sensor means for detecting the light intensity reflected by different locations of the open surfaces of the objects and for converting it into electric form. The sensor means in the device comprise at least a first telecentric imaging unit (11 or 12) having an optical axis. The device further comprises an angle mirror (13), and auxiliary mirrors (8) within the imaging area (K) of the telecentric imaging unit, between the telecentric imaging unit and the object. The object is positioned between the arms (3a, 3b) of the angle mirror, the telecentric imaging unit is directed towards combination of the object and the angle mirror; and the auxiliary mirrors are oriented and placed at such intervals from the telecentric imaging unit that the differences of imaging distances between the viewing directions (P1 and/or P2 and/or P3 and/or P4) either via the two arms, or via one arm of the angle mirror, or not via the arms are compensated as they pass via the auxiliary mirrors.
Patent NZ-552145-A (NZ)
Title: Educational toy with earth globe rotating within tummy
Inventor: CARDONA VICTOR A
IPC: G09B27/08
Filed: 2005-06-07
Abstract: An educational figurine 10 has a freely rotatable earth globe 14 mounted within a frame in the torso region. The globe may be illuminated and the figurine may produce audible messages concerning a geographical area depicted on the globe.
Patent NZ-556111-A (NZ)
Title: Cable management device
Inventor: SIMS DAVID JOHN
IPC: F16L3/00
Filed: 2007-06-22
Abstract: A cable finger assembly for use in a modular cable management system. The cable finger assembly comprises a cable finger and a cable flipper. The cable finger comprises a main body with an inner end including an attachment mechanism and an outer end including a cable flipper connector portion. The cable flipper has a first end adapted for connecting the flipper to the cable finger. The connection between the connector portion and the flipper first end is adapted to allow the cable flipper to be rotated relative to the main body, around an axis of rotation, by the application of an external force. The cable finger assembly includes a return mechanism which acts on the cable flipper when it is rotated away from the rest position to return the cable flipper to the rest position when the external force ceases to act on the flipper. A modular cable management system is also disclosed.
Patent NZ-560928-A (NZ)
Title: Purification of streptococcal agalactiae capsular polysaccharide
Inventor: COSTANTINO PAOLO
IPC: C08B37/00
Filed: 2006-02-01
Abstract: Disclosed is a process for purifying a Streptococcus agalactiae capsular polysaccharide, comprising the steps of: (a) removing contaminating nucleic acids and/or proteins from capsular polysaccharide in aqueous form by the use of alcoholic precipitation, wherein an alcohol and an aqueous metal cation are used to precipitate the nucleic acids and/or proteins leaving the polysaccharide in solution; (b) separating the precipitated material from the polysaccharide; and (c) diafiltration to remove fragments of group-specific saccharide from the polysaccharide.
Patent NZ-563369-A (NZ)
Title: Controlled-release formulation useful for treating disorders associated with hepatitus C virus
Inventor: MALCOLM BRUCE A
IPC: A61K38/04
Filed: 2006-05-31
Abstract: Disclosed are controlled release dosage formulations comprising a compound of formula (Ia), (Ib) or (Ic) and a controlled-release carrier wherein the carrier is a swellable polymer. Also disclosed is the use of the above formulation for the manufacture of a medicament for treating or ameliorating one or more symptoms of HCV or disorders associated with HCV.
Patent NZ-565106-A (NZ)
Title: Inductively powered gas discharge lamp with coplanar inductive heater coil and power coil
Inventor: BAARMAN DAVID W
IPC: F21Y101/00
Filed: 2006-08-01
Abstract: Disclosed is an inductively powered gas discharge lamp (10) having an ability to provide filament heating. The lamp comprises: an envelope (15) containing a discharge gas; first and second electrodes within the envelope; a first inductive power coil (14) coupled with the first electrode; and a first inductive heater coil (16) connected to the first electrode. The power coil is capable of receiving power from an inductive power supply to supply power to the first electrode. The heater coil is capable of applying a heating current to the first electrode, and is also capable of receiving power from the inductive power supply. The inductive heater coil and power coil are coplanar.
Patent NZ-577108-A (NZ)
Title: Synthetic peptide amides and dimers thereof of the kappa opioid receptor
Inventor: SCHTEINGART CLAUDIO D
IPC: A61K38/07
Filed: 2007-11-13
Abstract: Disclosed is a synthetic peptide amide having the formula: Xaa1-Xaa2-Xaa3-(Xaa4)p-G or a pharmaceutically acceptable salt, hydrate, solvate, acid salt hydrate, N-oxide or isomorphic crystalline form thereof wherein: each Xaa1 is independently selected from the group consisting of (A)(A')D-Phe, (á-Me)D-Phe, D-Tyr, D-Tic, D-phenylglycine, D-neopentylglycine, D-phenylglycine, D-homophenylalanine, and â-(E)D-Ala, wherein each (A) and each (A') are phenyl ring substituents independently selected from the group consisting of-H, -F, -Cl, -NO2, -CH3, -CF3, -CN, -CONH2, and wherein each (E) is independently selected from the group consisting of cyclobutyl, cyclopentyl, cyclohexyl, pyridyl, thienyl and thiazolyl; each Xaa2 is independently selected from the group consisting of (A)(A')D-Phe, (á-Me)D-Phe, D-1Nal, D-2Nal, D-Tyr, (E)D-Ala, and D-Tip; each Xaa3 is independently selected from the group consisting of D-Nle, D-Phe, cyclopentyl-D-Ala, D-Leu, (á-Me)D-Leu, D-Hle, D-Val, and D-Met; each Xaa4 is independently selected from the group consisting of (B)2D-Arg, (B)2D-nArg, (B)2D-Har, æ-(B)D-Hlys, D-Dap, ?-(B)D-Lys, ?-(B)2-D-Lys, D-Amf, amidino- D-Amf, ã-(B)2D-Dbu, ä-(B)2á-(B)D-Oni, D-2-amino-3(4-piperidyl)propionic acid, D-2-amino-3(2-aminopyrrolidyl)propionic acid, D-á-amino-amidino-propionic acid, á -amino-4-piperidineacetic acid, cis- á,4-diaminocyclohexane acetic acid, trans- á,4-diaminocyclohexaneacetic acid, cis- á-amino-4-methyl-aminocyclo-hexane acetic acid, trans-a-amino-4-methylaminocyclohexane acetic acid, á -amino-l-amidino-4-piperidineacetic acid, cis-á-amino-4-guanidino-cyclohexane acetic acid, and trans-a-amino-4-guanidinocyclohexane acetic acid, wherein each (B) is independently selected from the group consisting of -H and C1-C4 alkyl, and (B') is -H or (á-Me), and p is zero or 1; and G is as defined in the specification.
Patent NZ-580616-A (NZ)
Title: Improvements in & relating to initiating control of apparatus associated with a rotary dairy platform
Inventor: GOSS LESLIE DAVID
IPC: A01J5/00
Filed: 2009-10-22
Abstract: An initiation control apparatus (1) for use with a rotating dairy platform (3) is disclosed. The apparatus (1) comprises following means for following the rotational progress of the dairy platform (3). The following means is coupled to positioning means for determining a relative rotational position of the rotating dairy platform (3). The positioning means comprises rotating indexing means (8), sensing means and a controller (9). The sensing means interacts with the rotating indexing means (8) to determine direction and degree of rotation of the indexing means (8). The controller (9) receives and interprets information from the sensing means. The indexing means (8) comprises a rotating index element with optically different features. The sensing means comprises at least one optical emitter (15) and at least one optical receiver (16) capable of detecting and responding to optically different features of the rotating index element. The controller (9) is able to output a signal comprising at least one or both of a trigger signal to activate an event and information about the rotation position of the rotating dairy platform (3). The following means comprises at least one travelling wheel (4) capable of interacting with a feature of the rotating dairy platform (3).
Patent NZ-584938-A (NZ)
Title: Cell phone remote disease management by automatically reformatting data before transmitting the data from the cell phone
Inventor: MURACA JOHN R
IPC: G16H10/20
Filed: 2008-09-29
Abstract: 5849378 A method of remotely monitoring a patient and a remote disease management system are disclosed. The system comprises a patient cell phone acquiring data about a medical condition of a patient and automatically reformatting the acquired medical condition data into a developed text message format for a text messaging technology and transmitting the acquired medical condition data using the text messaging technology over cellular communication for the cell phone; and a server receiving the medical condition data and storing the medical condition data in the patient's medical record. Further is disclosed is the cell phone with for remotely monitoring a patient, comprising means for acquiring data about a medical condition of a patient by a cell phone; and means for automatically reformatting the acquired medical condition data into a developed text message format for a text messaging technology and transmitting the acquired medical condition data by the cell phone using the text messaging technology over cellular communication for the cell phone, to a server.
Patent NZ-585948-A (NZ)
Title: A diaphragm valve opperated by pressure difference across the valve having a guide bush on a guide pin
Inventor: COLLINS PHILIP JOHN
IPC: F16K1/42
Filed: 2010-06-04
Abstract: A diaphragm valve which includes a hollow body having one port to connect a hydraulic or pneumatic system to the interior of the body of the valve and another port to the interior of the body of the valve. The valve includes a diaphragm formed from a relatively softer material being movably mounted within the interior of the body and normally closing the one port, the diaphragm including side walls and a thin flexible annular skirt extending from the periphery of the diaphragm and integrally formed with a major part of the body of the diaphragm, the distal edge of the skirt being sealingly retained around a cavity behind the diaphragm, to movably mount the diaphragm within the interior of the body of the valve so that the diaphragm moves by flexing and/or folding of the skirt. The valve includes a guide pin extending through the cavity and an opening of the diaphragm and a guide bush of relatively harder material than the softer diaphragm retained within the opening and around the guide pin to form a channel there between. The channel traverses through the diaphragm from the port into the cavity behind the diaphragm such that when the pressure in the cavity behind the diaphragm falls below the pressure on the other side of the diaphragm, the diaphragm and bush will move away from the one port along the pin to open the one port to the interior of the body of the valve and will move to close the one port when the pressure in the cavity behind the diaphragm is equalised with the pressure on the other side of the diaphragm.
Patent NZ-589354-A (NZ)
Title: Fibre cement lining board which is pre-sealed and uses thereof
Inventor: COTTIER JOHN SYDNEY
IPC: E04B1/00
Filed: 2009-05-29
Abstract: 589354 Disclosed is an outer frame lining board (3) in the form of a fibre cement sheet which can be used as a replacement to building wrap. The board has a thickness of more than 3mm but less than 4mm, and is pre-sealed on at least one major face (5) prior to installation. The board is designed to result in a lining board which is easily handled and relatively inexpensive.
Patent NZ-597381-A (NZ)
Title: Thiazolidinedione analogues for the treatment of diabetes and inflammatory diseases
Inventor: COLCA GERARD R
IPC: A61K31/425
Filed: 2008-09-15
Abstract: ABSTRACT - 597381 The present disclosure is directed to the use of a compound of formula (I) or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of diabetes as well as an inflammatory disease such as rheumatoid arthritis, lupus, myasthenia gravis, muscular dystrophy, vasculitis, Chronic Obstructive Pulmonary Disease, inflammatory bowel disease, multiple schlerosis, acute allergic reactions, and transplant rejections, wherein: each of R1 and R4 is independently selected from H, halo, aliphatic, and alkoxy, wherein the aliphatic and alkoxy are optionally substituted with 1-3 of halo; R2 is halo, or hydroxy, and R'2 is H, or R2 and R'2 together form oxo; R3 is H; and Ring A is a phenyl, for use in the manufacture of a medicament for the treatment of diabetes, provided that the compound of formula (I) is not 5-(4-(2-(3-methoxyphenyl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione.
Patent NZ-597844-A (NZ)
Title: Preparation of soy protein isolate using calcium chloride extraction (”s703”)
Inventor: SEGALL KEVIN I
IPC: A23L11/00
Filed: 2010-06-30
Abstract: 597844 Disclosed herein is a process for preparing a soy protein product having a protein content of at least about 60 wt% (N x 6.25) d.b., preferably an isolate, by a procedure in which soy protein is extracted from a soy source material using an aqueous calcium chloride solution at low pH, generally about 1.5 to about 5, and separating the resulting aqueous soy protein solution from residual soy protein source. The resulting clarified aqueous soy protein solution may be diluted and the pH adjusted within the range of 1.5-5.0. The solution may be concentrated by ultrafiltration, diafiltered and then dried to provide the soy protein product. The soy protein product is soluble in acidic medium and produces transparent, heat stable solutions and hence may be used for protein fortification of soft drinks and sports drinks.
Patent NZ-600011-A (NZ)
Title: Improved organ protection, preservation and recovery
Inventor: DOBSON GEOFFREY PHILLIP
IPC: A61K31/4406
Filed: 2008-07-25
Abstract: 600011 Disclosed is a the use of : (i) a potassium channel opener or agonist or adenosine receptor agonist for example Adenosine; and (ii) a local anaesthetic for example the Class 1 B antiarrhythmic agent Lignocaine; and (iii) an opioid for example [D-Pen2,5]enkaphalin (DPDPE), in the preparation of a medicament for reducing damage to a postconditioned cell, tissue or organ following ischemia or trauma or during ischemia or reperfusion. Postconditioning is a particular therapy where there is rapid intermittent interruptions of blood flow in the early phase of reperfusion.
Patent NZ-601084-A (NZ)
Title: Pcsk9 antagonists
Inventor: RUE SARAH
IPC: A61K39/395
Filed: 2010-12-10
Abstract: Disclosed is an antibody that binds to proprotein convertase subtilisin/kexin type 9 (PCSK9), wherein the antibody comprises a heavy chain V-segment and a light chain V-segment, each of which comprises a complementarity determining region 1 (CDR1), a complementarity determining region 2 (CDR2), and a complementarity determining region 3 (CDR3); wherein: i) the CDR1 of the heavy chain V-segment comprises SEQ ID NO:7; ii) the CDR2 of the heavy chain V-segment comprises SEQ ID NO:10; iii) the heavy chain CDR3 comprises an amino acid sequence selected from the group consisting of SEQ ID NO:12 and SEQ ID NO:13; iv) the CDR1 of the light chain V-segment comprises SEQ ID NO:21; v) the CDR2 of the light chain V-segment comprises SEQ ID NO:24; and vi) the light chain CDR3 comprises SEQ ID NO:26; wherein the sequences are as disclosed in the specification. Also disclosed is the use of the above mentioned antibody in the manufacture of a medicament for reducing LDL-C in an individual.